Normal range: Negative
Comment: Antibodies against glutamic acid decarboxylase (anti-GAD) is very important test for the detection of type I diabetes mellitus or laten autoimmune diabetes in adult (i.e. slow or laten type I diabetes). Its detection in patients developing diabetes is very important as it is the “most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as type I diabetes on clinical ground”. Anti-GAD are associated with 70% in Type I diabetes patient and in 60% of “slow or laten type I diabetes”. It can be present with anti-insulin antibodies and / or anti-insulin antibodies. It can be the only
antibody present in “slow onset diabetes type I “and can be the only predictor that these patient are going to be insulin dependent in the future. Performing anti- GAD in all diabetic patients is very important predictor to those that may require insulin therapy in the future. Antibodies against glutamic acid decarboxylase (anti-GAD) is very important test for the detection of type I diabetes mellitus or laten autoimmune diabetes in adult i.e. slow or laten type I diabetes
Sample: Serum